217 related articles for article (PubMed ID: 32586571)
1. Clinical and Biological Prognostic Factors in Follicular Lymphoma.
Patel AA; Smith SM
Hematol Oncol Clin North Am; 2020 Aug; 34(4):647-662. PubMed ID: 32586571
[TBL] [Abstract][Full Text] [Related]
2. Early Progression of Follicular Lymphoma: Biology and Treatment.
Lipof JJ; Barr PM
Hematol Oncol Clin North Am; 2020 Aug; 34(4):757-769. PubMed ID: 32586579
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of follicular lymphoma: A comprehensive review.
Dada R
Eur J Haematol; 2019 Sep; 103(3):152-163. PubMed ID: 31270855
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Histologic Transformation.
Casulo C
Hematol Oncol Clin North Am; 2020 Aug; 34(4):785-794. PubMed ID: 32586581
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of histologic grade and Ki-67 proliferation index in follicular lymphoma.
Xue T; Yu BH; Yan WH; Jiang XN; Tian T; Zhou XY; Li XQ
Hematol Oncol; 2020 Dec; 38(5):665-672. PubMed ID: 32627854
[TBL] [Abstract][Full Text] [Related]
6. How I manage patients with follicular lymphoma.
Casulo C
Br J Haematol; 2019 Aug; 186(4):513-523. PubMed ID: 31173345
[TBL] [Abstract][Full Text] [Related]
7. Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma.
Cohen JB; Kahl BS
Hematol Oncol Clin North Am; 2020 Aug; 34(4):663-672. PubMed ID: 32586572
[TBL] [Abstract][Full Text] [Related]
8. Follicular lymphoma grade 3: review and updates.
Vaidyanathan G; Czuczman MS
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):431-5. PubMed ID: 25066038
[TBL] [Abstract][Full Text] [Related]
9. Follicular lymphoma: 2020 update on diagnosis and management.
Freedman A; Jacobsen E
Am J Hematol; 2020 Mar; 95(3):316-327. PubMed ID: 31814159
[TBL] [Abstract][Full Text] [Related]
10. Initial Treatment of High Tumor Burden Follicular Lymphoma.
Freeman CL; Sehn LH
Hematol Oncol Clin North Am; 2020 Aug; 34(4):673-687. PubMed ID: 32586573
[TBL] [Abstract][Full Text] [Related]
11. The Adverse Consequences of Initial Watchful Waiting for Patients With Follicular Lymphoma.
Davies GA; Ghosh S; Oh DH; Manna M; Peters AC; Stewart CA; Stewart DA
Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):829-835. PubMed ID: 30243571
[TBL] [Abstract][Full Text] [Related]
12. The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.
Blaker YN; Spetalen S; Brodtkorb M; Lingjaerde OC; Beiske K; Østenstad B; Sander B; Wahlin BE; Melen CM; Myklebust JH; Holte H; Delabie J; Smeland EB
Br J Haematol; 2016 Oct; 175(1):102-14. PubMed ID: 27341313
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of patients with nodal marginal zone lymphoma compared to follicular lymphoma: similar presentation, but differences in prognostic factors and rate of transformation.
van den Brand M; van der Velden WJ; Diets IJ; Ector GI; de Haan AF; Stevens WB; Hebeda KM; Groenen PJ; van Krieken HJ
Leuk Lymphoma; 2016 Jul; 57(7):1649-56. PubMed ID: 26694256
[TBL] [Abstract][Full Text] [Related]
14. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.
Giné E; Montoto S; Bosch F; Arenillas L; Mercadal S; Villamor N; Martínez A; Colomo L; Campo E; Montserrat E; López-Guillermo A
Ann Oncol; 2006 Oct; 17(10):1539-45. PubMed ID: 16940035
[TBL] [Abstract][Full Text] [Related]
15. Can histologic transformation of follicular lymphoma be predicted and prevented?
Kridel R; Sehn LH; Gascoyne RD
Blood; 2017 Jul; 130(3):258-266. PubMed ID: 28408460
[TBL] [Abstract][Full Text] [Related]
16. Follicular Lymphoma: Diagnostic and Prognostic Considerations in Initial Treatment Approach.
Boughan KM; Caimi PF
Curr Oncol Rep; 2019 May; 21(7):63. PubMed ID: 31119485
[TBL] [Abstract][Full Text] [Related]
17. Follicular non-Hodgkin's lymphoma.
Hayashi D; Lee JC; Devenney-Cakir B; Zaim S; Ounadjela S; Solal-Céligny P; Juweid M; Guermazi A
Clin Radiol; 2010 May; 65(5):408-20. PubMed ID: 20380942
[TBL] [Abstract][Full Text] [Related]
18. Recent landmark studies in follicular lymphoma.
Sorigue M; Sancho JM
Blood Rev; 2019 May; 35():68-80. PubMed ID: 30928169
[TBL] [Abstract][Full Text] [Related]
19. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.
Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma.
Umino K; Fujiwara SI; Ito S; Mashima K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Ashizawa M; Hatano K; Okazuka K; Sato K; Oh I; Ohmine K; Suzuki T; Muroi K; Kanda Y
Leuk Lymphoma; 2017 Feb; 58(2):316-323. PubMed ID: 27267694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]